Nov.9 to 12, Jiangsu Ehai Pharmaceutical Co., Ltd. was audited by CFDA expert team. The final decisions by the expert team that Ehai meets the requirements of cGMP standard, which is two years earlier than the deadline. By the end of 2015, all the pharmaceutical manufacturing enterprises should comply with cGMP Regulations. According to the data released by CFDA in September, the passing rate of non-sterile drugs manufacturing enterprises is 19.4%.